The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Open accessAbstract
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and an angiogenic inducer in a variety of in vivo models.Hypoxia has been shown to be a major inducer of VEGF gene transcription.The tyrosine kinases Flt-1 (VEGFR-1) and Flk-1/KDR (VEGFR-2) are highaffinity VEGF receptors.The role of VEGF in developmental angiogenesis is emphasized by the finding that loss of a single VEGF allele results in defective vascularization and early embryonic lethality.VEGF is critical also for reproductive and bone angiogenesis.Substantial evidence also implicates VEGF as a mediator of pathological angiogenesis.In situ hybridization studies demonstrate expression of VEGF mRNA in the majority of human tumors.Anti-VEGF monoclonal antibodies and other VEGF inhibitors block the growth of several tumor cell lines in nude mice.Clinical trials with various VEGF inhibitors in a variety of malignancies are ongoing.Very recently, an anti-VEGF monoclonal antibody (bevacizumab; Avastin) has been approved by the Food and Drug Administration as a first-line treatment for metastatic colorectal cancer in combination with chemotherapy.Furthermore, VEGF is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration.(Endocrine Reviews 25: 581-611, 2004) I. Introduction II.Historical Note on Angiogenic Factors III.Identification of VEGF IV.Activities of VEGF A. Mitogenesis, angiogenesis, and endothelial survival B. Effects of VEGF on bone marrow cells and hematopoiesis C. Enhancement of vascular permeability and hemodynamic effects V. VEGF Isoforms VI.Regulation of VEGF Gene Expression A. Oxygen tension B. Growth factors, hormones, and oncogenes VII.VEGFRs A. VEGFR-1 (Flt-1) B. VEGFR-2 (KDR, human; Flk-1, mouse) C. Neuropilin (NP)1 and NP2 VIII.Role of VEGF in Physiological Angiogenesis A. Embryonic and postnatal development B. Skeletal growth and endochondral bone formation C. Angiogenesis in endocrine glands IX.Role of VEGF in Pathological Conditions A. Solid tumors B. Hematological malignancies C. Intraocular neovascular syndromes D. Inflammatory disorders and brain edema
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–428 of 428
Sone, H., Kawakami, Y., Sakauchi, M., Nakamura, Y., Takahashi, A., Shimano, H., Okuda, Y., Segawa, T., Suzuki, H., & Yamada, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4395 · Cited by 107
Rosenberg, C. L., Motokura, T., Kronenberg, H. M., & Arnold, A. (1993) · PubMed · Cited by 107
Ocular neovascularization: a valuable model system
Campochiaro, P. A., & Hackett, S. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206773 · Cited by 106
In Vitro Angiogenic and Proteolytic Properties of Bovine Lymphatic Endothelial Cells
Pepper, M. S., Wasi, S., Ferrara, N., Orci, L., & Montesano, R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1042 · Cited by 104
Self-citationZimmermann, R. C., Xiao, E., Husami, N., Sauer, M. V., Løbo, R. A., Kitajewski, J., & Ferin, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7181 · Cited by 102
Tang, T. T.-L., & Lasky, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302042200 · Cited by 94
Harrigan, M. R., Ennis, S. R., Sullivan, S. E., & Keep, R. F. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-002-1035-1 · Cited by 91
Kishimoto, J., Ehama, R., Ge, Y., Kobayashi, T., Nishiyama, T., Detmar, M. J., & Burgeson, R. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64522-1 · Cited by 86
Schoenberger, J., Grimm, D. G., Kossmehl, P. P., Infanger, M., Kurth, E., & Eilles, C. (2003) · Endocrinology · doi:10.1210/en.2003-1228 · Cited by 81
Shifren, J. L., Mesiano, S. A., Taylor, R. N., Ferrara, N., & Jaffe, R. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4730 · Cited by 78
Self-citationMatsumoto, Y., Tanaka, K., Hirata, G., Hanada, M., Matsuda, S., Shuto, T., & Iwamoto, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5824 · Cited by 77
Lange, T., Guttmann‐Raviv, N., Baruch, L., Machluf, M., & Neufeld, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212224200 · Cited by 77
Vascular endothelial growth factor. The trigger for neovascularization in the eye.
Ferrara, N. (1995) · PubMed · Cited by 77
Self-citationDavis-Smyth, T., Presta, L. G., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3216 · Cited by 73
Self-citationZimmermann, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.768 · Cited by 71
Mesri, E. A., Federoff, H. J., & Brownlee, M. (1995) · Circulation Research · doi:10.1161/01.res.76.2.161 · Cited by 70
Angiogenesis inhibitors suffer new setback
Garber, K. (2002) · Nature Biotechnology · doi:10.1038/nbt1102-1067 · Cited by 57
Mueller, M. D., Vigne, J., Pritts, E. A., Chao, V. A., Dreher, E. F., & Taylor, R. N. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04577-6 · Cited by 57
Maru, Y., Yamaguchi, S., & Shibuya, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201786 · Cited by 57
Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo
Soh, E. Y., Eigelberger, M. S., Kim, K. J., Wong, M. G., Young, D. M., Clark, O. H., & Duh, Q. (2000) · Surgery · doi:10.1067/msy.2000.110430 · Cited by 56
Tulandi, T., Saleh, A., Morris, D., Jacobs, H. S., Payne, N. N., & Tan, S. L. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00684-1 · Cited by 53
LeCouter, J. E., Lin, R., Frantz, G. D., Zhang, Z., Hillan, K. J., & Ferrara, N. (2003) · Endocrinology · doi:10.1210/en.2002-0146 · Cited by 53
Self-citationInduction of ovulation with menotropins in women with polycystic ovary syndrome
Kemmann, E., Tavakoli, F., Shelden, R. M., & Jones, J. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90675-x · Cited by 48
PHILLIPS, H., ARMANI, M., Stavrou, D., Ferrara, N., & Westphal, M. (1993) · International Journal of Oncology · doi:10.3892/ijo.2.6.913 · Cited by 43
Self-citationDennis, P. A., & Rifkin, D. B. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041440112 · Cited by 40
Kobayashi, H., Okada, Y., Asahina, T., Gotoh, J., & Terao, T. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0200363 · Cited by 40
Shi, Y., & Ferrara, N. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9966 · Cited by 39
Self-citationGonadotropin‐Mediated Regulation of the Murine VEGF Expression in MA‐10 Leydig Cells
Schwarzenbach, H., Chakrabarti, G., Paust, H. J., & Mukhopadhyay, A. K. (2004) · Journal of Andrology · doi:10.1002/j.1939-4640.2004.tb02768.x · Cited by 25
Cited by
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Self-citationDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Self-citationTumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Metadata
- Authors
- Ferrara, N.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-08-01
- Volume
- 25
- Issue
- 4
- Pages
- 581-611
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2077129920
- Cited by
- 3,687
- References
- 428
- FWCI
- 54.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.